Cargando…
Lymphangiogenesis-inducing vaccines elicit potent and long-lasting T cell immunity against melanomas
In melanoma, the induction of lymphatic growth (lymphangiogenesis) has long been correlated with metastasis and poor prognosis, but we recently showed it can synergistically enhance cancer immunotherapy and boost T cell immunity. Here, we develop a translational approach for exploiting this “lymphan...
Autores principales: | Sasso, Maria Stella, Mitrousis, Nikolaos, Wang, Yue, Briquez, Priscilla S., Hauert, Sylvie, Ishihara, Jun, Hubbell, Jeffrey A., Swartz, Melody A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990326/ https://www.ncbi.nlm.nih.gov/pubmed/33762337 http://dx.doi.org/10.1126/sciadv.abe4362 |
Ejemplares similares
-
Engineering Targeting Materials for Therapeutic Cancer Vaccines
por: Briquez, Priscilla S., et al.
Publicado: (2020) -
Membrane-localized neoantigens predict the efficacy of cancer immunotherapy
por: Goldberger, Zoe, et al.
Publicado: (2023) -
Generation of potent cellular and humoral immunity against SARS-CoV-2 antigens via conjugation to a polymeric glyco-adjuvant
por: Gray, Laura T., et al.
Publicado: (2021) -
Polymersomes decorated with SARS-CoV-2 spike protein receptor binding domain elicit robust humoral and cellular immunity
por: Volpatti, Lisa R., et al.
Publicado: (2021) -
Polymersomes Decorated with the SARS-CoV-2
Spike Protein Receptor-Binding Domain Elicit Robust Humoral and Cellular
Immunity
por: Volpatti, Lisa R., et al.
Publicado: (2021)